Cryptocurrency & Digital Assets

Skechers' new partnership with Birmingham Phoenix signals a revolution in cricket, fueled by private equity and a brand's bold play for sports dominance.

SXSW debuts its first Filmmakers Jacket, a plastic-free, plant-based creation by UNLESS, signaling a major shift in sustainable event merchandise.

With its new FRESHPREY line, premium brand ORIJEN challenges fresh food incumbents, leveraging extreme marketing and a 'WholePrey' philosophy.

The acquisition of Perfusion Life expands Integration Health's network, aiming to solve critical staffing shortages for life-saving perfusionist roles.

Lionsgate and Scentbird's new John Wick perfume is more than a novelty; it's a strategic play in the booming billion-dollar fandom economy.

A massive donation of absorbent underwear highlights the silent struggle of millions and the vital role of corporate-nonprofit partnerships in America.

Newly published research brings scientific rigor to the controversial kratom plant, influencing policy from the FDA to statehouses across the nation.

Suave enters Canada exclusively at Walmart, armed with data showing 79% of Canadians would drop premium brands for an affordable, effective alternative.

BioRestorative Therapies is leveraging its clinical-grade regenerative medicine to disrupt the aesthetics industry. Can science beat marketing?

A new Chinese fantasy drama personifies ancient instruments into living spirits. Here's how 'The Melody of Love' is set to change global entertainment.

A new survey reveals over half of Americans delay healthcare, creating a 'health debt' crisis fueled by cost fears and scheduling conflicts for younger generations.

A new partnership between Always and The Fibroid Foundation aims to break the silence on heavy periods and fibroids, combining product innovation with advocacy.

Starton Therapeutics files patents to combine its continuous low-dose therapy, STAR-LLD, with CAR-T, aiming to enhance cancer-killing power and durability.

With a key federal security clearance, Dejero's connectivity platform is now available for U.S. agencies, promising enhanced security and field operations.

With a melanoma drug on track for 2027 and a deep pipeline, Immatics' 2025 net loss is part of a larger strategy to dominate PRAME cancer therapy.

With a new outpatient model, NexCure aims to bring life-saving cancer treatments like CAR-T closer to home, tackling a major healthcare bottleneck.

Biotech firm Immunis, Inc. secures a promising drug candidate to treat a debilitating side effect of Parkinson's therapy, offering hope to millions.

Canada's top cannabis firm launches a fast-acting drink, leveraging brand power and nano-tech to shake up the evolving beverage market.

Following key acquisitions, the AI firm pivots to a vertically integrated defense powerhouse, forecasting explosive growth backed by a swelling order backlog.

A Chinese firm's innovative probiotic packaging just won a top design award, solving a key industry problem and signaling a new era for 'Made in China'.